Invivyd, Inc. IVVD
0.55 USD -0.04 (-6.10%)
As ofNov 16, 2026, 1:15 PM EST
0.5471 Day range 0.585
0.528 52-week range 3.07
- YTD
- -77.87%
- 1 year
- -76.74%
News
zacks.com Invivyd, Inc. (IVVD) Reports Q3 Loss, Misses Revenue Estimates Invivyd, Inc. (IVVD) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.06 per share a year ago.benzinga.com Invivyd Q3 EPS $(0.10) Beats $(0.13) Estimate, Sales $15.449M Beat $15.033M Estimate Invivyd (NASDAQ:IVVD) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 66.67 percent decrease over losses of $(0.06) per…
globenewswire.com Invivyd Reports Third Quarter 2026 Financial Results and Recent Business Highlights NEW HAVEN, Conn., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced financial results for the third quarter ended September 30, 2026, and recent business highlights.benzinga.com Invivyd Presents Preclinical Data Showing Measles Antibody Candidate VMS063 Demonstrates Potent Antiviral Activity Against Contemporary Measles Fusion Protein Variants VMS063 is a novel, potential first- and best-in-class monoclonal antibody investigational candidate discovered by Invivyd VMS063 demonstrated potent in vitro antiviral activity against contemporary…
